tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Immunocore Holdings PLC

IMCR
Add to Watchlist
33.810USD
-0.060-0.18%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.72BMarket Cap
LossP/E TTM

Immunocore Holdings PLC

33.810
-0.060-0.18%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

IMCR Financials

See Immunocore Holdings PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Immunocore Holdings PLC Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/0.01
Revenue / Forecast
--/110.23M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
400.02M
28.95%
EPS(YoY)
-0.71
30.97%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
Financial Indicators
EPS
154.82%0.26
-25.10%-0.59
-102.01%0.00
11.82%-0.20
120.47%0.10
-19.24%-0.47
256.12%0.17
35.79%-0.23
-21.38%-0.49
36.31%-0.40
--0.05
---0.36
---0.40
---0.63
----
----
----
----
----
----
----
Revenue
13.63%106.68M
24.30%104.48M
29.22%103.69M
29.93%97.96M
33.16%93.88M
19.80%84.05M
23.17%80.25M
26.16%75.40M
28.99%70.50M
22.42%70.16M
34.44%65.15M
48.56%59.77M
81.35%54.66M
--57.31M
493.55%48.46M
402.44%40.23M
164.49%30.14M
-4.88%8.17M
--8.01M
--11.40M
----
Net Profit
158.23%12.97M
-26.46%-30.06M
-102.03%-177.00K
11.33%-10.30M
120.56%5.02M
-20.48%-23.77M
262.59%8.74M
34.05%-11.62M
-25.64%-24.44M
34.28%-19.73M
-67.11%2.41M
-128.91%-17.61M
10.08%-19.45M
---30.02M
117.64%7.33M
83.29%-7.69M
45.94%-21.63M
-66.27%-41.53M
---46.04M
---40.01M
----
Net Margin
127.26%12.16%
-1.73%-28.77%
-101.57%-0.17%
31.75%-10.51%
115.44%5.35%
-0.57%-28.28%
194.39%10.89%
47.73%-15.41%
2.59%-34.66%
46.32%-28.12%
--3.70%
---29.47%
---35.58%
---52.38%
----
----
----
----
----
----
----
Gross Margin
0.48%99.59%
-2.20%97.41%
0.06%99.51%
1.23%98.94%
-0.54%99.11%
-0.11%99.61%
-0.13%99.44%
-0.42%97.74%
0.05%99.65%
-0.06%99.71%
--99.57%
--98.15%
--99.60%
--99.77%
----
----
----
----
----
----
----
Debt to assets ratio
-3.59%36.72%
-4.90%36.83%
-11.96%35.61%
-15.39%36.22%
-13.48%38.09%
381.63%38.73%
166.56%40.45%
180.59%42.81%
--44.02%
-11.39%8.04%
--15.17%
--15.26%
----
--9.08%
----
----
----
----
----
----
----
Income Statement
Revenue
13.63%106.68M
24.30%104.48M
29.22%103.69M
29.93%97.96M
33.16%93.88M
19.80%84.05M
23.17%80.25M
26.16%75.40M
28.99%70.50M
22.42%70.16M
34.44%65.15M
48.56%59.77M
81.35%54.66M
--57.31M
493.55%48.46M
402.44%40.23M
164.49%30.14M
-4.88%8.17M
--8.01M
--11.40M
----
Operating profit
301.33%7.28M
-1.23%-19.69M
15.66%-7.17M
7.13%-14.88M
86.35%-3.62M
-14.07%-19.45M
-861.21%-8.50M
18.85%-16.02M
-80.25%-26.49M
-82.28%-17.05M
-112.18%-884.51K
-124.51%-19.74M
33.43%-14.70M
---9.36M
117.02%7.26M
81.75%-8.79M
49.75%-22.07M
-41.15%-42.66M
---48.18M
---43.93M
----
Net Profit
158.23%12.97M
-26.46%-30.06M
-102.03%-177.00K
11.33%-10.30M
120.56%5.02M
-20.48%-23.77M
262.59%8.74M
34.05%-11.62M
-25.64%-24.44M
34.28%-19.73M
-67.11%2.41M
-128.91%-17.61M
10.08%-19.45M
---30.02M
117.64%7.33M
83.29%-7.69M
45.94%-21.63M
-66.27%-41.53M
---46.04M
---40.01M
----
Balance Sheet
Current assets
5.82%1.00B
7.19%996.74M
1.68%1.02B
4.75%1.00B
2.44%948.63M
75.84%929.86M
98.39%1.01B
90.65%956.86M
--926.04M
11.57%528.82M
12.59%507.02M
60.33%501.88M
----
--473.98M
15.32%450.33M
-27.32%313.02M
-31.68%319.64M
293.45%390.51M
269.11%430.71M
--467.82M
--209.10M
Total current liabilities
60.97%240.11M
16.27%246.70M
-36.02%170.35M
-8.11%170.08M
-3.95%149.16M
52.63%212.18M
123.64%266.25M
57.88%185.10M
--155.29M
37.87%139.02M
38.15%119.05M
49.17%117.24M
----
--100.83M
15.62%86.18M
3.94%78.60M
-7.09%69.76M
21.46%74.53M
39.33%75.62M
--75.09M
--75.20M
Total assets
4.29%1.07B
5.72%1.07B
1.65%1.10B
5.77%1.08B
3.42%1.03B
69.10%1.01B
91.60%1.08B
82.93%1.02B
--993.99M
13.33%597.00M
14.07%566.09M
55.46%559.44M
----
--526.76M
11.37%496.25M
-26.28%359.85M
-29.47%370.40M
163.66%445.57M
156.31%488.11M
--525.18M
--269.62M
Total liabilities
4.45%678.42M
5.77%686.24M
-0.12%705.94M
4.47%693.91M
2.38%649.53M
184.36%648.79M
235.79%706.81M
220.60%664.23M
--634.45M
21.45%228.16M
25.86%210.49M
29.99%207.19M
----
--187.86M
-3.66%167.24M
-11.92%159.39M
-16.39%155.94M
16.57%173.59M
21.13%180.96M
--186.50M
--193.95M
Total equity
4.01%393.67M
5.63%381.03M
4.96%396.56M
8.17%388.48M
5.27%378.48M
-2.20%360.72M
6.25%377.83M
1.95%359.14M
--359.53M
8.83%368.84M
8.08%355.60M
75.72%352.25M
----
--338.90M
20.97%329.02M
-34.74%200.46M
-36.68%214.46M
1254.37%271.98M
648.41%307.15M
--338.68M
--75.67M
Cash Flow Statement
Net operating income
-3266.67%-13.78M
-134.07%-32.66M
-121.09%-4.46M
10.62%25.96M
109.48%435.00K
---13.95M
86.03%21.13M
489.15%23.47M
-143.52%-4.59M
----
19.28%11.36M
134.51%3.98M
125.49%10.54M
----
132.58%9.52M
74.63%-11.55M
-15.51%-41.35M
-5921.63%-29.22M
---45.50M
---35.80M
17.81%-27.17M
Net investment
-56.51%4.22M
75.14%-880.00K
734.30%5.25M
91.32%-30.41M
2356.28%9.70M
34.69%-3.54M
61.87%-828.00K
-36355.61%-350.33M
85.67%-430.00K
---5.42M
-1009.32%-2.17M
-265.76%-960.98K
-1582.48%-3.00M
----
218.67%238.79K
-4803.05%-262.73K
-617.78%-178.37K
-126.16%-201.23K
--5.59K
--34.45K
216.69%2.39M
Net financing
-74.28%656.00K
108.32%4.28M
842.42%1.87M
548.66%3.67M
-99.36%2.55M
-250.05%-51.51M
-97.56%198.00K
-112.44%-818.00K
6350.76%396.01M
--34.33M
-94.12%8.12M
1072.61%6.58M
443.66%6.14M
----
9473.39%138.24M
69.96%-676.32K
-100.62%-1.79M
-6.21%-1.47M
---2.25M
--288.50M
9128.73%121.43M

FAQs

What is the total revenue of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its total revenue reached 400.02M, with a year-on-year change of 310.20M.

What are the current assets of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its current assets were 996.74M, with a year-on-year change of 7.19.

What are the total assets of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its total assets of Immunocore Holdings PLC were 1.07B, with a year-on-year change of 5.72.

What are the total liabilities of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its total liabilities of Immunocore Holdings PLC were 686.24M, with a year-on-year change of 5.77.

What is the total equity of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its total equity of Immunocore Holdings PLC was 381.03M, with a year-on-year change of 5.63.

What is the net operating income of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its net operating income of Immunocore Holdings PLC was -45.35M, with a year-on-year change of 35.63.

What is the net investment of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its net investment of Immunocore Holdings PLC was -16.34M, with a year-on-year change of 95.40.

What is the net financing of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its net financing of Immunocore Holdings PLC was 12.37M, with a year-on-year change of -96.40.

What is the Earnings Per Share (EPS) of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -0.71, with a year-on-year change of 30.97.

What is the net income of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its net income was -35.51M, with a year-on-year change of 30.48.

What is the net margin of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its net profit margin was -8.88, with a year-on-year change of 46.09.

What is the gross margin of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its gross margin was 98.73, with a year-on-year change of -0.39.

What is the debt-to-asset ratio of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its debt-to-asset ratio was 36.83, with a year-on-year change of -4.90.

What is the Return on Equity (ROE) of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its Return on Equity (ROE) was -9.58, with a year-on-year change of 31.63.

What is the Return on Assets (ROA) of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its Return on Assets (ROA) was -3.42, with a year-on-year change of 46.22.

What is the operating profit of Immunocore Holdings PLC?

According to Immunocore Holdings PLC's FY2025 earnings report, its operating profit was -45.35M, with a year-on-year change of 35.63.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy